Infectious Disease and Microbiology – Morganella morganii

Overview

Morganella morganii is an aerobic Gram-negative bacillus in the Enterobacterales group that is widely distributed and most often causes opportunistic healthcare-associated infections.

It is particularly associated with urinary tract infection, pneumonia, bacteremia, and sepsis, especially in hospitalized or medically complex patients. It may also be present in the mouths of snakes and can occasionally contribute to infection after snake bites.

⸻

Classification

Genus: Morganella

Species: Morganella morganii

Type: Aerobic Gram-negative bacillus

Order: Enterobacterales

⸻

Microbiologic Characteristics

M. morganii is generally:

• Gram-negative

• Rod-shaped

• Facultatively anaerobic despite the source describing it as aerobic

• Motile

• A member of the normal intestinal flora in humans and animals

It is related microbiologically to organisms such as:

• Proteus

• Providencia

⸻

Incubation Period

The incubation period is:

Unknown

Because most infections are endogenous or healthcare-associated, a specific incubation period is usually not defined.

⸻

Epidemiology

Morganella morganii occurs:

Worldwide

It is generally a low-virulence organism but can become pathogenic in the presence of:

• Hospitalization

• Indwelling urinary catheters

• Advanced age

• Immunosuppression

• Recent surgery

• Broad-spectrum antibiotic exposure

• Other severe underlying illness

⸻

Nosocomial Infection

The source emphasizes that M. morganii most commonly causes:

Healthcare-associated infection

Important sites include:

• Urinary tract

• Respiratory tract

• Bloodstream

• Wounds

⸻

Urinary Tract Infection

One of the most common clinical manifestations is:

Urinary tract infection

This is especially associated with:

• Urinary catheterization

• Structural urinary tract disease

• Prolonged hospitalization

⸻

Urease Production

M. morganii is:

Urease positive

This can contribute to:

Alkaline urine

and may promote urinary crystal or stone formation in some patients.

⸻

High-Yield Urinary Pattern

Hospitalized patient

Urinary catheter

Gram-negative bacillus

Urease positivity

→ Consider Morganella morganii, Proteus, or Providencia

⸻

Pulmonary Infection

M. morganii may cause:

Pneumonia

particularly in:

• Hospitalized patients

• Patients with chronic illness

• Ventilated patients

• Immunocompromised hosts

Pulmonary infection is usually healthcare-associated rather than community-acquired.

⸻

Bacteremia and Sepsis

M. morganii can enter the bloodstream and cause:

Bacteremia

or

Sepsis

Common sources include:

• Urinary tract

• Intra-abdominal infection

• Wounds

• Respiratory tract

Severe infection is more likely in medically fragile patients.

⸻

Snake Bite-Associated Infection

The source notes that M. morganii may be found in:

Snake oral flora

Therefore, it can occasionally contribute to:

Secondary infection of snake bite wounds

These infections are often polymicrobial.

⸻

Clinical Implication

After a snake bite, wound infection may involve:

• Morganella

• Aeromonas

• Enteric Gram-negative bacilli

• Anaerobic organisms

The exact microbiology depends on the snake species and environmental exposure.

⸻

Diagnosis

The primary diagnostic method is:

Culture

Relevant specimens may include:

• Urine

• Blood

• Respiratory secretions

• Wound material

• Other normally sterile body fluids

⸻

Laboratory Identification

M. morganii may be identified using:

• Routine biochemical testing

• Automated microbiology systems

• MALDI-TOF mass spectrometry

Susceptibility testing is particularly important because resistance patterns can vary.

⸻

Antibiotic Resistance

An important feature of M. morganii is the presence of:

Chromosomal AmpC beta-lactamase

This can confer resistance to several beta-lactam antibiotics and may lead to resistance emerging during therapy.

⸻

AmpC Clinical Significance

AmpC activity may reduce susceptibility to:

• Ampicillin

• Amoxicillin

• First-generation cephalosporins

• Some later-generation cephalosporins

For serious infection, treatment should be based on:

Antimicrobial susceptibility results

⸻

High-Yield Resistance Pattern

Morganella morganii

Enterobacterales organism

AmpC beta-lactamase potential

→ Be cautious with cephalosporins in serious infections

⸻

Treatment

The source lists:

• Carbapenems, including imipenem and meropenem

• Ciprofloxacin

These may be appropriate for susceptible isolates, especially in severe infection.

⸻

Additional Treatment Options

The source also lists:

• Third-generation cephalosporins

• Aztreonam

• Ofloxacin

• Piperacillin–tazobactam

• Aminoglycosides

However, resistance is increasingly important, so therapy should be:

Susceptibility guided

⸻

Third-Generation Cephalosporins

The source specifically notes:

Increasing resistance

with third-generation cephalosporins.

Because inducible or derepressed AmpC beta-lactamase activity can occur, these drugs may be unreliable in some serious infections.

⸻

Treatment Principle

Severe M. morganii infection

↓

Obtain cultures

↓

Perform susceptibility testing

↓

Select active antimicrobial therapy

↓

Address source control

This may include:

• Removing infected catheters

• Draining abscesses

• Managing obstructed urinary systems

• Debriding infected wounds when necessary

⸻

Morganella vs. Proteus

Morganella morganii

→ Gram-negative rod

→ Urease positive

→ Nosocomial UTI and sepsis

→ Motile

→ AmpC beta-lactamase potential

→ Does not typically produce the dramatic swarming pattern associated with Proteus

Proteus mirabilis

→ Gram-negative rod

→ Strongly urease positive

→ Swarming motility

→ UTI and struvite stones

→ Characteristic fishy odor may occur

⸻

Morganella vs. Providencia

Morganella

→ Healthcare-associated UTI

→ Sepsis

→ Urease positive

→ AmpC-associated resistance

Providencia

→ Particularly associated with long-term urinary catheters

→ UTI and bacteremia

→ Often multidrug resistant

Both belong to the Proteeae group and may have overlapping clinical settings.

⸻

High-Yield Clinical Pattern

Hospitalized or catheterized patient

UTI, pneumonia, or sepsis

Gram-negative bacillus

Urease positive

Potential AmpC resistance

→ Think Morganella morganii

⸻

Exam Essentials

Genus: Morganella

Species: M. morganii

Type: Gram-negative bacillus

Order: Enterobacterales

Motility: Motile

Urease: Positive

Distribution: Worldwide

Typical setting: Nosocomial/opportunistic infection

Major infections: UTI, pneumonia, bacteremia, sepsis

Special exposure: Snake bite wounds

Diagnosis: Culture

Resistance mechanism: Chromosomal AmpC beta-lactamase

Source treatment: Carbapenem or ciprofloxacin

Other options: Piperacillin–tazobactam, aztreonam, fluoroquinolones, aminoglycosides, selected cephalosporins

Treatment principle: Use susceptibility-guided therapy, particularly for severe infection

⸻

Key clinical pearl: Morganella morganii is a urease-positive opportunistic Gram-negative rod that commonly causes healthcare-associated UTI and sepsis. Its ability to express AmpC beta-lactamase makes resistance an important treatment consideration, so serious infections should be managed with susceptibility-guided therapy and appropriate source control.

Infectious Disease and Microbiology – Moraxella (Branhamella) Species

Overview

Moraxella species are aerobic Gram-negative coccobacilli that commonly colonize the human upper respiratory tract and can cause a variety of infections. The most clinically important species is Moraxella catarrhalis, formerly called Branhamella catarrhalis.

These organisms are especially associated with otitis media, sinusitis, bronchitis, and pneumonia, and they may also cause conjunctivitis, bacteremia, endocarditis, and arthritis.

Classification

Genus: Moraxella

Important species:

• M. atlantae

• M. catarrhalis

• M. lacunata

• M. nonliquefaciens

• M. osloensis

• M. phenylpyruvica

Type: Aerobic Gram-negative coccobacillus

Historical Name

Moraxella catarrhalis was historically classified as:

Branhamella catarrhalis

Older literature may therefore refer to the organism as:

Branhamella

Microbiologic Characteristics

Moraxella species are generally:

• Aerobic

• Gram-negative

• Coccobacillary in appearance

• Part of the normal respiratory/oral flora

M. catarrhalis is often described microscopically as a Gram-negative diplococcus, which can resemble Neisseria species.

Incubation Period

The incubation period is:

Unknown

Because many Moraxella infections arise from organisms already colonizing the upper respiratory tract, there is usually no clearly defined incubation period.

Epidemiology

M. catarrhalis is a:

Common human respiratory pathogen

Moraxella species may also exist as normal flora of the:

• Oropharynx

• Upper respiratory tract

• Oral cavity

Colonization is particularly common in children.

Major Risk Groups

Clinically significant disease occurs commonly in:

• Young children

• Older adults

• Patients with chronic pulmonary disease

• Patients with COPD

• Immunocompromised individuals

M. catarrhalis is particularly important in respiratory exacerbations among patients with chronic lung disease.

Otitis Media

M. catarrhalis is an important cause of:

Acute otitis media

especially in children.

It is one of the classic bacterial causes together with:

• Streptococcus pneumoniae

• Nontypeable Haemophilus influenzae

• Moraxella catarrhalis

High-Yield Otitis Pattern

Child with acute otitis media

→ Think of:

S. pneumoniae

• ●

H. influenzae

• ●

M. catarrhalis

Sinusitis

M. catarrhalis is also a recognized cause of:

Acute bacterial sinusitis

particularly in children.

Clinical manifestations can include:

• Nasal congestion

• Purulent nasal discharge

• Facial pain or pressure

• Fever

Lower Respiratory Tract Infection

Moraxella, particularly M. catarrhalis, can cause:

• Acute bronchitis

• COPD exacerbations

• Pneumonia

• Bronchopneumonia

COPD Association

One of the most important adult associations is:

Acute exacerbation of chronic obstructive pulmonary disease

M. catarrhalis commonly infects or colonizes the respiratory tract of older adults with chronic lung disease.

High-Yield COPD Pattern

Older patient with COPD

• ●

Increased cough

• ●

Purulent sputum

• ●

Respiratory exacerbation

→ Consider Moraxella catarrhalis

Laryngitis

The source also lists:

Laryngitis

among upper respiratory tract infections that may be associated with Moraxella species.

Ocular Infections

Neonatal Conjunctivitis

The source describes:

Neonatal conjunctivitis

usually associated with:

M. catarrhalis

Blepharoconjunctivitis

Several Moraxella species can cause:

Blepharoconjunctivitis

The species classically associated with this manifestation is:

Moraxella lacunata

High-Yield Eye Association

M. lacunata

→ Blepharoconjunctivitis

Invasive Disease

Although less common than respiratory disease, Moraxella species can occasionally cause:

• Bacteremia

• Endocarditis

• Septic arthritis

These manifestations are more likely in patients with significant comorbid illness or impaired immunity.

Diagnosis

The primary diagnostic method is:

Culture

Clinical specimens may include:

• Respiratory secretions

• Blood

• Conjunctival material

• Synovial fluid

Species identification can help establish the significance of unusual isolates.

Laboratory Characteristics of M. catarrhalis

M. catarrhalis is typically:

• Gram-negative

• Diplococcal/coccobacillary

• Oxidase positive

• Catalase positive

It can resemble Neisseria microscopically but has distinct biochemical characteristics.

Beta-Lactamase Production

A major therapeutic feature is that:

M. catarrhalis frequently produces beta-lactamase

This means that simple:

Ampicillin

or

Amoxicillin alone

may be ineffective.

High-Yield Resistance Pattern

Moraxella catarrhalis

• ●

Beta-lactamase production

→ Avoid relying on plain amoxicillin when resistance is suspected

→ Amoxicillin–clavulanate provides beta-lactamase protection

Treatment

The source lists:

Amoxicillin–clavulanate

as first-line treatment.

This is a logical choice because clavulanate inhibits many beta-lactamases produced by M. catarrhalis.

Additional Treatment Options

The source also lists:

• Macrolides

• Fluoroquinolones

• Second-generation cephalosporins

• Trimethoprim–sulfamethoxazole

Treatment should be chosen according to:

• Site of infection

• Severity

• Local resistance patterns

• Patient allergies

• Susceptibility results when available

Treatment Principle

Suspected M. catarrhalis infection

• ●

Frequent beta-lactamase production

↓

Choose an agent stable to or protected from beta-lactamase

Examples:

Amoxicillin–clavulanate

or another active alternative

Moraxella catarrhalis vs. Haemophilus influenzae

M. catarrhalis

→ Gram-negative diplococcus/coccobacillus

→ Otitis media

→ Sinusitis

→ COPD exacerbation

→ Frequent beta-lactamase production

Nontypeable H. influenzae

→ Small Gram-negative coccobacillus

→ Otitis media

→ Sinusitis

→ COPD exacerbation

→ Also commonly produces beta-lactamase

Both are major respiratory pathogens.

Moraxella catarrhalis vs. Neisseria

Moraxella catarrhalis

→ Gram-negative diplococcus

→ Respiratory tract pathogen

→ Otitis, sinusitis, COPD exacerbation

→ Usually noninvasive

Neisseria meningitidis

→ Gram-negative diplococcus

→ Meningitis

→ Meningococcemia

Neisseria gonorrhoeae

→ Gram-negative diplococcus

→ Gonorrhea

→ Pelvic inflammatory disease

→ Neonatal conjunctivitis

High-Yield Clinical Pattern

Child with otitis media or sinusitis

or

Older patient with COPD exacerbation

• ●

Gram-negative diplococcus/coccobacillus

• ●

Frequent beta-lactamase production

→ Think Moraxella catarrhalis

Exam Essentials

Genus: Moraxella

Former genus/name: Branhamella

Major species: M. catarrhalis

Type: Aerobic Gram-negative coccobacillus/diplococcus

Normal habitat: Upper respiratory/oral flora

Major infections: Otitis media, sinusitis, bronchitis, COPD exacerbation, pneumonia

Eye association: M. lacunata → blepharoconjunctivitis

Other infections: Bacteremia, endocarditis, arthritis

Diagnosis: Culture

Important resistance mechanism: Beta-lactamase production

Source treatment: Amoxicillin–clavulanate

Alternatives: Macrolide, fluoroquinolone, second-generation cephalosporin, TMP-SMX

Key clinical pearl: Moraxella catarrhalis is a common respiratory pathogen, especially in children with otitis/sinusitis and adults with COPD exacerbations. Because it frequently produces beta-lactamase, amoxicillin–clavulanate is a classic treatment choice.

Infectious Disease and Microbiology – Molluscum Contagiosum Virus

Overview

Molluscum contagiosum virus (MCV) is a double-stranded DNA poxvirus that causes molluscum contagiosum, a common superficial skin infection characterized by small, firm, pearly or waxy papules with central umbilication.

The infection occurs worldwide and spreads through direct skin-to-skin contact, sexual contact, autoinoculation, and contaminated fomites. Disease is usually mild and self-limited in immunocompetent individuals but may become extensive in patients with significant immunodeficiency.

Classification

Family: Poxviridae

Genus: Molluscipoxvirus

Virus: Molluscum contagiosum virus

Genome: Double-stranded DNA

Symmetry: Complex

Host: Humans

Microbiologic Characteristics

Molluscum contagiosum virus is:

• Enveloped

• Double-stranded DNA virus

• Large and structurally complex

• A member of the poxvirus family

Like other poxviruses, MCV is unusual among DNA viruses because its replication occurs primarily in the:

Cytoplasm

rather than the nucleus.

Incubation Period

The incubation period is typically:

2–7 weeks

However, it may occasionally extend for as long as:

6 months

Epidemiology

Molluscum contagiosum has a:

Worldwide distribution

Humans are the natural reservoir and source of infection.

It is particularly common among:

• Children

• Sexually active adults

• Individuals with close skin-to-skin exposure

• Patients with impaired cellular immunity

Transmission

Transmission occurs through:

• Direct skin-to-skin contact

• Sexual contact

• Contaminated fomites

• Shared towels or personal items

• Autoinoculation

Autoinoculation can spread lesions from one part of the patient’s body to another, particularly after scratching.

Clinical Infection

The characteristic lesion is a:

Discrete, dome-shaped, waxy or pearly papule with central umbilication

The source describes most patients as having approximately:

2–20 lesions

although the number can vary substantially.

Appearance of Lesions

Typical lesions are:

• Firm

• Smooth

• Flesh-colored, pearly, or waxy

• Dome-shaped

• Usually painless

• Centrally umbilicated

The central depression is one of the most recognizable features of molluscum contagiosum.

High-Yield Lesion Pattern

Small pearly papule

• ●

Smooth dome-shaped surface

• ●

Central umbilication

→ Think molluscum contagiosum

Distribution

In children, lesions commonly occur on:

• Trunk

• Extremities

• Face

• Skin folds

In adults, sexually transmitted infection may produce lesions around the:

• Genital region

• Lower abdomen

• Inner thighs

• Perineum

Autoinoculation

Patients may spread the virus to adjacent areas through:

Scratching or manipulation of lesions

This can result in multiple lesions appearing in a linear or clustered distribution.

Molluscum Contagiosum in Immunocompromised Patients

Patients with substantial immunodeficiency, including advanced HIV infection, may develop:

• Numerous lesions

• Larger lesions

• Giant lesions

• Confluent lesions

• Extensive skin involvement

• Persistent or treatment-resistant disease

Facial involvement can be particularly prominent in advanced immunosuppression.

High-Yield Immunodeficiency Pattern

Numerous large or giant umbilicated papules

• ●

Extensive or unusual distribution

→ Consider significant immunodeficiency

In the appropriate clinical context, extensive molluscum contagiosum should prompt consideration of impaired cellular immunity.

Diagnosis

Diagnosis is usually:

Clinical

The characteristic centrally umbilicated papules are generally sufficient for diagnosis.

Histopathology

When the diagnosis is uncertain, biopsy can demonstrate characteristic intracytoplasmic inclusion bodies known as:

Henderson–Patterson bodies

or:

Molluscum bodies

These represent large viral inclusion bodies within infected epidermal cells.

High-Yield Pathology

Umbilicated papules

• ●

Large eosinophilic intracytoplasmic Henderson–Patterson bodies

→ Molluscum contagiosum

Electron Microscopy

The source also lists:

Electron microscopy

which can demonstrate characteristic poxvirus particles.

However, electron microscopy is generally unnecessary for routine clinical diagnosis.

Differential Diagnosis

In immunocompromised patients, molluscum-like lesions can resemble disseminated fungal infections, particularly:

Cryptococcus

and

Histoplasma

Both can produce umbilicated papules, especially in patients with advanced immunodeficiency.

Important Diagnostic Warning

Immunocompromised patient

• ●

Umbilicated skin lesions

does not automatically mean molluscum contagiosum.

Consider:

• Molluscum contagiosum

• Disseminated cryptococcosis

• Disseminated histoplasmosis

Biopsy may be necessary when the presentation is atypical.

Natural Course

In immunocompetent patients, molluscum contagiosum is generally:

Self-limited

Individual lesions may resolve spontaneously, although complete clearance of all lesions can take considerably longer than the 2–4 months described in the source.

Therefore, uncomplicated disease can often be managed with:

Observation

when treatment is not otherwise necessary.

Treatment

Treatment is not always required in immunocompetent patients because spontaneous resolution is common.

Treatment may be considered when lesions are:

• Symptomatic

• Numerous

• Cosmetically troublesome

• Persistently spreading

• Located in problematic areas

• Associated with significant transmission concerns

Cryotherapy

Lesions can be destroyed using:

Liquid nitrogen cryotherapy

This is an effective physical treatment but may cause discomfort, blistering, or pigmentary changes.

Curettage

Another treatment is:

Curettage

which physically removes individual lesions.

This can be effective when relatively few lesions are present.

Cantharidin

The source lists topical:

Cantharidin

which produces controlled blistering and destruction of treated lesions.

It is an established treatment option for selected patients.

Other Topical Therapy

The source also lists keratolytic or peeling preparations such as:

Salicylic acid

These agents may help remove superficial lesions in selected circumstances.

Treatment in Immunocompromised Patients

In patients with HIV-associated immunodeficiency, an important component of management is:

Immune reconstitution with effective antiretroviral therapy

Improvement in cellular immunity may lead to substantial regression of extensive molluscum lesions.

Treatment Principle

Immunocompetent patient

→ Often self-limited

→ Observation or local lesion-directed therapy

Immunocompromised patient

→ May have extensive/refractory lesions

→ Local treatment as appropriate

→ Restore immune function whenever possible

Prevention

Prevention focuses on reducing direct and indirect transmission.

Important measures include:

• Avoiding direct contact with active lesions

• Avoiding scratching or picking lesions

• Avoiding sharing towels or personal items

• Covering lesions when appropriate

• Avoiding sexual contact involving affected areas until appropriately evaluated/managed

Molluscum Contagiosum vs. Herpes Simplex

Molluscum contagiosum

→ Firm, pearly papules

→ Central umbilication

→ Usually painless

→ Poxvirus

Herpes simplex

→ Grouped vesicles that may ulcerate

→ Frequently painful or burning

→ Recurrence common

→ Herpesvirus

Molluscum Contagiosum vs. Cryptococcus

Molluscum contagiosum

→ Classic pearly umbilicated papules

→ Usually superficial skin infection

→ Henderson–Patterson bodies

Disseminated cryptococcosis

→ May produce molluscum-like umbilicated lesions

→ Particularly concerning in severe immunosuppression

→ Represents systemic fungal disease

Thus, atypical umbilicated lesions in a severely immunocompromised patient may warrant biopsy rather than assuming they are molluscum.

High-Yield Clinical Pattern

Child or young adult

• ●

Multiple painless, pearly/waxy papules

• ●

Central umbilication

→ Think Molluscum contagiosum virus

Exam Essentials

Virus: Molluscum contagiosum virus

Family: Poxviridae

Genus: Molluscipoxvirus

Genome: Double-stranded DNA

Envelope: Present

Symmetry: Complex

Replication: Cytoplasm

Reservoir: Humans

Transmission: Skin-to-skin contact, sexual contact, fomites, autoinoculation

Incubation: Usually 2–7 weeks, potentially longer

Classic lesion: Pearly/waxy centrally umbilicated papule

Histology: Henderson–Patterson (molluscum) bodies

Immunodeficiency: Larger, more numerous, persistent lesions

Important differential in immunocompromised patients: Cryptococcus and Histoplasma

Diagnosis: Usually clinical; biopsy if uncertain

Natural history: Usually self-limited in immunocompetent hosts

Local treatments: Cryotherapy, curettage, cantharidin, selected keratolytic therapies

HIV-associated disease: Immune reconstitution with antiretroviral therapy is important

Prevention: Avoid direct lesion contact and sharing contaminated personal items

Key clinical pearl: Molluscum contagiosum is a poxvirus infection classically producing painless, pearly, centrally umbilicated papules with Henderson–Patterson bodies on histology. Very large, numerous, or persistent lesions should raise concern for significant immunodeficiency, while molluscum-like lesions in an immunocompromised patient should also prompt consideration of disseminated cryptococcosis or histoplasmosis.

Infectious Disease and Microbiology – Mobiluncus Species

Overview

Mobiluncus species are anaerobic, curved, motile bacilli associated mainly with bacterial vaginosis (BV). The principal species are Mobiluncus curtisii and M. mulieris.

They are often found together with other organisms involved in the polymicrobial vaginal dysbiosis of BV, especially Gardnerella vaginalis. Their presence supports the diagnosis of BV but is not required for it.

Classification

Genus: Mobiluncus

Important species:

• M. curtisii

• M. mulieris

Type: Anaerobic curved bacillus

Microbiologic Characteristics

Mobiluncus species are:

• Anaerobic

• Curved bacilli

• Motile

• Often Gram-variable

They may appear Gram-negative on staining, but their cell-wall structure is more consistent with Gram-positive organisms.

This Gram-variable appearance can make identification challenging.

Incubation Period

The incubation period is:

Unknown

Because Mobiluncus is part of a polymicrobial alteration of vaginal flora rather than a classic single-pathogen infection, a precise incubation period is not generally defined.

Epidemiology

Mobiluncus organisms are strongly associated with:

Bacterial vaginosis

The source reports that Mobiluncus can be isolated from vaginal specimens in:

More than 50% of women with BV

compared with approximately:

5% of women without BV

This indicates a strong association, although Mobiluncus alone does not define the disease.

Bacterial Vaginosis

BV is best understood as:

Vaginal dysbiosis

rather than infection caused by a single bacterium.

There is a reduction in protective:

Lactobacillus

species and an increase in anaerobic or facultative organisms such as:

• Gardnerella vaginalis

• Mobiluncus species

• Other anaerobic bacteria

Role of Mobiluncus

Mobiluncus is commonly found in BV but generally acts as part of a:

Polymicrobial microbial community

rather than as an isolated primary pathogen.

Thus:

Mobiluncus present

does not necessarily mean:

Mobiluncus alone caused the vaginal symptoms

Clinical Manifestations

Clinical manifestations are primarily those of:

Bacterial vaginosis

Typical features include:

• Thin, homogeneous vaginal discharge

• Gray-white discharge

• Characteristic fishy odor

• Vaginal pH above 4.5

• Minimal inflammatory response

Prominent vulvar inflammation or marked pruritus is less typical of BV and should suggest alternative diagnoses.

Gardnerella Association

The source emphasizes that other organisms, particularly:

Gardnerella vaginalis

are frequently isolated together with Mobiluncus.

A useful concept is:

BV = polymicrobial dysbiosis

rather than:

BV = infection by Gardnerella alone

or:

BV = infection by Mobiluncus alone

Diagnosis

The source lists:

• Anaerobic culture

• Direct immunofluorescence of vaginal fluid

However, routine diagnosis of BV generally relies more on clinical and microscopic criteria than culture of individual organisms.

Amsel Criteria

A common clinical approach is the:

Amsel criteria

BV is supported when at least 3 of 4 findings are present:

• Thin, homogeneous vaginal discharge

• Vaginal pH >4.5

• Positive amine or whiff test

• Clue cells on microscopy

Nugent Score

Gram-stained vaginal specimens can also be evaluated using the:

Nugent scoring system

This assesses the balance among:

• Large Gram-positive Lactobacillus-type rods

• Small Gram-variable rods such as Gardnerella

• Curved Gram-variable rods consistent with Mobiluncus

Thus, curved Mobiluncus-like organisms on Gram stain can contribute to the microscopic diagnosis of BV.

High-Yield Microscopic Clue

Curved Gram-variable rods

• ●

Reduced Lactobacillus

• ●

Clue cells

→ Support bacterial vaginosis

Culture

Anaerobic culture can grow Mobiluncus, but culture is generally not required for routine diagnosis of BV.

This is because Mobiluncus can occasionally be present in women without BV, and BV is defined by the overall alteration in vaginal microbiota.

Treatment

The source lists:

Penicillin

as a treatment directed against Mobiluncus.

It also lists:

Amoxicillin–clavulanate

as an alternative.

However, when Mobiluncus is detected in the setting of BV, treatment should target:

Bacterial vaginosis as a syndrome

rather than one organism in isolation.

Metronidazole

The source correctly emphasizes:

Metronidazole is the drug of choice for bacterial vaginosis regardless of whether Mobiluncus is detected.

This is the most important therapeutic principle.

Other BV Therapy

Another commonly used treatment for BV is:

Clindamycin

which provides activity against many of the anaerobic organisms involved in vaginal dysbiosis.

Treatment Principle

Patient with bacterial vaginosis

• ●

Mobiluncus detected or not detected

↓

Treat the BV syndrome

↓

Metronidazole or another recommended BV regimen

The presence of Mobiluncus does not normally require a completely separate treatment strategy.

Mobiluncus vs. Gardnerella vaginalis

Mobiluncus

→ Curved, motile anaerobic bacillus

→ Gram-variable

→ Strongly associated with BV

→ Often seen as curved rods on Gram stain

Gardnerella vaginalis

→ Small pleomorphic Gram-variable coccobacillus

→ Frequently associated with BV

→ Important contributor to clue-cell formation and vaginal biofilm

Both are part of the broader polymicrobial process.

Bacterial Vaginosis vs. Candida Vaginitis

Bacterial vaginosis

→ Thin homogeneous discharge

→ Fishy odor

→ pH >4.5

→ Clue cells

→ Usually little inflammation

→ Gardnerella and anaerobes including Mobiluncus

Vulvovaginal candidiasis

→ Thick white discharge

→ Prominent pruritus/inflammation

→ Usually normal vaginal pH

→ Budding yeast or pseudohyphae

High-Yield Clinical Pattern

Thin gray-white vaginal discharge

• ●

Fishy odor

• ●

Vaginal pH >4.5

• ●

Clue cells

• ●

Curved Gram-variable rods

→ Think bacterial vaginosis with Mobiluncus species as part of the polymicrobial flora

Exam Essentials

Genus: Mobiluncus

Important species: M. curtisii, M. mulieris

Type: Anaerobic curved bacillus

Motility: Motile

Gram stain: Frequently Gram-variable

Major association: Bacterial vaginosis

Other major organism in BV: Gardnerella vaginalis

Clinical concept: BV is polymicrobial dysbiosis

Microscopic clue: Curved Gram-variable rods

BV diagnosis: Amsel criteria or Nugent scoring

Source organism-directed treatment: Penicillin

Additional source treatment: Amoxicillin–clavulanate

Most important BV treatment principle: Metronidazole treats bacterial vaginosis regardless of whether Mobiluncus is detected

Key clinical pearl: Mobiluncus species are curved, motile, Gram-variable anaerobic bacilli strongly associated with bacterial vaginosis. Their presence supports BV, but BV is a polymicrobial dysbiosis, so treatment is directed at the syndrome—classically with metronidazole—rather than at Mobiluncus alone.

Microbiology - Microsporum Species

Microsporum is a genus of filamentous fungi (molds) that belongs to the dermatophyte group. Important species include Microsporum audouinii and Microsporum canis, along with several other species. These fungi mainly infect keratinized tissues, particularly the skin and hair, although nail infection may occasionally occur.

Microsporum infections occur worldwide. Some species are associated with animals; for example, M. canis is commonly linked to cats and dogs and can be transmitted to humans. The incubation period is variable and is not always clearly defined.

Microsporum can cause different forms of tinea (dermatophytosis), including tinea capitis of the scalp and hair, tinea corporis of the body, and tinea faciei of the face. Nail infection or onychomycosis is less commonly caused by Microsporum compared with other dermatophytes.

Diagnosis is made by collecting skin scrapings or infected hairs from the lesion. The fungus may then be identified using direct microscopic examination, fungal culture, or other laboratory methods.

Treatment depends on the site of infection. Localized skin infections may be treated with topical terbinafine, usually for several weeks. Tinea capitis generally requires oral antifungal therapy because topical treatment alone does not penetrate the infected hair follicles adequately. Oral agents may include griseofulvin, terbinafine, or itraconazole, depending on the organism and clinical situation.

If onychomycosis occurs, treatment is usually prolonged and may continue for several months. Itraconazole may also be used for certain dermatophyte infections, particularly when topical treatment is not sufficient.

Infectious Disease and Microbiology – Microsporidia

Overview

Microsporidia are a large group of obligate intracellular, spore-forming organisms that cause microsporidiosis. They were historically classified as protozoa, but molecular and phylogenetic evidence now places them within or very close to the fungal lineage.

Human infection is particularly important in immunocompromised patients, in whom microsporidia can cause severe chronic watery diarrhea and disseminated disease. Immunocompetent individuals may have mild disease or remain asymptomatic.

Classification

Historically, microsporidia were placed in the phylum Microspora, containing more than 100 genera and approximately 1,000 described species in the source.

Organisms of recognized or historical clinical significance include:

• Enterocytozoon bieneusi

• Encephalitozoon cuniculi

• Encephalitozoon hellem

• Nosema species

• Pleistophora species

• Vittaforma corneae

• Other microsporidia

Important Taxonomic Correction

The source lists:

Enterocytozoon cuniculi

and

Enterocytozoon hellem

These are more correctly classified as:

Encephalitozoon cuniculi

and

Encephalitozoon hellem

The source also contains several older names because the taxonomy of microsporidia has undergone substantial revision.

Microbiologic Characteristics

Microsporidia are:

• Obligate intracellular organisms

• Spore-forming

• Extremely small

• Historically classified as protozoa

• Currently considered highly specialized fungus-related organisms

They cannot complete their replicative life cycle independently outside host cells.

Spores

The environmentally resistant and infectious form is the:

Spore

Microsporidial spores are very small and contain a highly characteristic structure called the:

Polar tube

The polar tube is one of the most distinctive features of microsporidia.

Polar Tube

When an infectious spore encounters an appropriate host cell:

Spore activation

↓

Polar tube rapidly extrudes

↓

Polar tube penetrates host-cell membrane

↓

Infectious material is injected into host cell

↓

Intracellular replication

↓

New spores form

This unusual mechanism of cellular invasion is a major high-yield microbiologic feature.

Epidemiology

Microsporidia have a:

Worldwide distribution

However, many aspects of their environmental reservoirs and transmission remain incompletely understood.

Disease became particularly recognized in association with severe immunosuppression, especially during the HIV/AIDS epidemic.

Transmission

Possible routes include:

• Fecal–oral transmission

• Contaminated food or water

• Urine-associated environmental transmission

• Direct environmental exposure

The exact transmission route can vary among different microsporidial species.

Microsporidiosis

Clinical manifestations depend strongly on:

Microsporidial species

• ●

Site of infection

• ●

Host immune status

Immunocompetent individuals may remain asymptomatic, whereas immunocompromised patients can develop chronic or disseminated disease.

Gastrointestinal Disease

Chronic Watery Diarrhea

The most important gastrointestinal manifestation is:

Watery, nonbloody diarrhea

This can become severe and persistent in immunocompromised patients.

Clinical Manifestations

Intestinal microsporidiosis may produce:

• Chronic watery diarrhea

• Abdominal discomfort

• Malabsorption

• Weight loss

• Dehydration

Severe prolonged disease is especially associated with advanced immunosuppression.

Enterocytozoon bieneusi

Enterocytozoon bieneusi is an important cause of:

Intestinal microsporidiosis

It is particularly associated with:

Chronic diarrhea in immunocompromised patients

Encephalitozoon Species

Important species include:

Encephalitozoon intestinalis

Encephalitozoon cuniculi

and

Encephalitozoon hellem

These organisms can cause intestinal disease but have greater potential than E. bieneusi for infection outside the gastrointestinal tract.

Disseminated Infection

Microsporidia can spread beyond the intestine and involve:

• Biliary tract

• Respiratory tract

• Kidneys and urinary tract

• Central nervous system

• Eyes

• Muscles

• Other organs

Dissemination occurs primarily in severely immunocompromised individuals.

Biliary Disease

Microsporidiosis can involve the:

Biliary tree

and contribute to biliary inflammation or cholangitis-like disease, particularly in severely immunocompromised patients.

Pulmonary Disease

Pulmonary microsporidiosis may produce:

• Cough

• Dyspnea

• Pulmonary infiltrates

• Pneumonitis

It is primarily an opportunistic manifestation.

Central Nervous System Disease

Rarely, disseminated microsporidiosis may involve the:

Central nervous system

Neurologic manifestations depend on the location and extent of infection.

Ocular Microsporidiosis

Microsporidia can infect the:

• Conjunctiva

• Cornea

and produce:

Keratoconjunctivitis

or

Keratitis

Clinical Features

Ocular disease may cause:

• Eye redness

• Pain or irritation

• Photophobia

• Foreign-body sensation

• Blurred vision

Some ocular microsporidial infections can occur even in otherwise immunocompetent individuals.

High-Yield Ocular Pattern

Keratoconjunctivitis

• ●

Tiny intracellular spore-forming organisms

• ●

Characteristic polar tube

→ Consider microsporidiosis

Diagnosis

The source emphasizes:

Microscopic examination of stool or affected tissue

Diagnosis may involve:

• Stool examination

• Tissue biopsy

• Light microscopy

• Specialized staining

• Electron microscopy

• Molecular testing where available

Stool Examination

For intestinal disease, microsporidial spores can be detected in:

Stool specimens

Because the spores are extremely small, specialized staining and careful microscopic examination may be necessary.

Histopathology

Biopsy of affected tissue can demonstrate:

Intracellular microsporidial organisms

Histologic examination can be particularly useful in intestinal, ocular, muscular, or disseminated infection.

Electron Microscopy

Electron microscopy historically played an important role because it can demonstrate the characteristic:

Polar tube

and detailed internal architecture of the spore.

However, molecular and specialized staining techniques have reduced reliance on electron microscopy for routine diagnosis.

Molecular Diagnosis

PCR-based testing can help:

• Confirm microsporidial infection

• Identify the species

• Distinguish morphologically similar organisms

Species identification can be clinically useful because treatment response varies considerably among microsporidia.

Treatment

Albendazole

The source lists:

Albendazole

as the principal treatment.

Albendazole has useful activity against several microsporidial species, particularly:

Encephalitozoon species

Important Treatment Limitation

Treatment is species dependent.

A particularly important distinction is:

Encephalitozoon species

→ Often responsive to albendazole

whereas:

Enterocytozoon bieneusi

→ Generally responds poorly to albendazole

Therefore, identifying the causative species can influence management.

Ocular Treatment

The source describes:

Topical fumagillin preparations

as potentially effective for:

• Conjunctival microsporidiosis

• Corneal microsporidiosis

Local ophthalmologic management may also be required.

Importance of Immune Restoration

In immunocompromised patients, particularly those with HIV, improvement of immune function is a major component of management.

Effective immune restoration can substantially improve control of:

Chronic intestinal and disseminated microsporidiosis

Microsporidia in Immunocompetent vs. Immunocompromised Hosts

Immunocompetent

→ Frequently asymptomatic

→ May develop self-limited gastrointestinal disease

→ Ocular infection can occur

Immunocompromised

→ Chronic severe watery diarrhea

→ Malabsorption and weight loss

→ Biliary disease

→ Pulmonary disease

→ CNS involvement

→ Disseminated infection

High-Yield Clinical Pattern

Severely immunocompromised patient

• ●

Chronic watery, nonbloody diarrhea

• ●

Weight loss/malabsorption

• ●

Tiny intracellular spore-forming organisms in stool or intestinal tissue

→ Think Microsporidia

High-Yield Microbiology Pattern

Obligate intracellular organism

• ●

Spore formation

• ●

Unique polar tube used to inject infectious material into host cells

→ Think Microsporidia

Exam Essentials

Organisms: Microsporidia

Modern classification: Highly specialized fungus-related organisms

Historical classification: Protozoa

Lifestyle: Obligate intracellular

Infectious form: Spore

Characteristic structure: Polar tube

Transmission: Primarily fecal–oral/environmental exposure

Important species: Enterocytozoon bieneusi, Encephalitozoon intestinalis, E. cuniculi, E. hellem

Major risk group: Immunocompromised patients

Classic infection: Chronic watery, nonbloody diarrhea

Other sites: Biliary tract, lungs, CNS, urinary tract, eyes and muscle

Ocular disease: Keratitis/keratoconjunctivitis

Diagnosis: Stool or tissue microscopy, specialized stains, histology and PCR

Historical ultrastructural diagnosis: Electron microscopy

Source treatment: Albendazole

Albendazole activity: Particularly useful for Encephalitozoon species

E. bieneusi: Often poorly responsive to albendazole

Ocular treatment: Topical fumagillin may be useful

Immunocompromised patients: Immune restoration is an important component of management

Key clinical pearl: Microsporidia are tiny obligate intracellular, spore-forming, fungus-related organisms characterized by a unique polar tube. Think of them particularly in an immunocompromised patient with chronic watery nonbloody diarrhea; Encephalitozoon infections often respond to albendazole, whereas Enterocytozoon bieneusi is much less susceptible.

Infectious Disease and Microbiology – Methylobacterium Species

Overview

Methylobacterium species are aerobic Gram-negative bacilli that are widely distributed in the environment but are very rare causes of human infection. They are distinctive because many species produce characteristic pink-pigmented colonies in culture.

Human disease is usually opportunistic and occurs particularly in immunocompromised patients or in association with indwelling medical devices. Important manifestations include bacteremia and peritoneal dialysis-associated peritonitis.

Classification

Genus: Methylobacterium

Important species:

• M. extorquens

• M. mesophilicum

• Other Methylobacterium species

Type: Aerobic Gram-negative bacillus

Historical Classification

Methylobacterium species were previously classified under the genus:

Protomonas

Therefore, older microbiology literature may refer to these organisms as:

Protomonas species

Microbiologic Characteristics

Methylobacterium organisms are:

• Aerobic

• Gram-negative bacilli

• Environmental organisms

• Generally slow-growing

• Characteristically associated with pink-pigmented colonies

The pink coloration is an important laboratory clue.

Pink-Pigmented Colonies

A particularly characteristic feature of Methylobacterium is the production of:

Pink to reddish-pink colonies

For this reason, these organisms are sometimes described as:

Pink-pigmented facultative methylotrophs

The unusual pigmentation can help distinguish them from many other nonfermenting environmental Gram-negative bacilli.

Incubation Period

The incubation period is:

Unknown

Because infections are usually opportunistic and often associated with medical devices or environmental exposure, a clearly defined incubation period is generally unavailable.

Epidemiology

Human infection is:

Very rare

However, recognition of Methylobacterium infections has increased with improved microbiologic identification techniques and greater awareness of opportunistic environmental organisms.

Environmental Reservoir

Methylobacterium species are widely distributed in:

• Water

• Soil

• Plants

• Moist environmental surfaces

Their ability to persist in water-associated environments is particularly relevant to healthcare-associated infection.

Risk Factors

Invasive infection occurs primarily in patients with:

• Immunosuppression

• Malignancy

• Indwelling vascular catheters

• Peritoneal dialysis catheters

• Other implanted medical devices

Thus, isolation of Methylobacterium from a normally sterile specimen in a vulnerable patient should not automatically be dismissed as contamination.

Bacteremia

One of the most important clinical manifestations is:

Bacteremia

This is particularly associated with immunocompromised individuals and patients with intravascular devices.

Catheter-Associated Infection

Because Methylobacterium is an environmental organism with an affinity for moist environments, infection can occur in association with:

Central venous catheters

Persistent bacteremia may indicate colonization or infection of an indwelling device.

High-Yield Bacteremia Pattern

Immunocompromised patient

• ●

Indwelling vascular catheter

• ●

Gram-negative bacillus

• ●

Pink-pigmented colonies

→ Think Methylobacterium

Peritoneal Dialysis-Associated Peritonitis

Methylobacterium species may cause:

Peritonitis

in patients undergoing:

Peritoneal dialysis

The dialysis catheter provides a potential route for introduction and persistence of the organism.

Clinical Features

Peritoneal dialysis-associated infection may present with:

• Abdominal pain

• Fever

• Cloudy dialysis fluid

• Peritoneal inflammatory findings

Culture of the peritoneal dialysis fluid can establish the microbiologic diagnosis.

Opportunistic Infection

Methylobacterium is considered a:

Low-virulence opportunistic pathogen

Most clinically significant infections occur when normal host defenses are impaired or when foreign material provides a surface for persistent infection.

Colonization vs. True Infection

Because Methylobacterium is an environmental organism, a positive culture should be interpreted according to the clinical setting.

Evidence supporting true infection includes:

• Repeated positive cultures

• Isolation from a normally sterile site

• Compatible clinical illness

• Immunosuppression

• Presence of an infected catheter or device

Diagnosis

The primary diagnostic method is:

Culture

Identification is based on growth characteristics and microbiologic testing.

Laboratory Clue

A particularly useful clue is:

Pink-pigmented colonies

When an unusual aerobic Gram-negative bacillus with pink pigmentation is recovered from blood or another sterile specimen, Methylobacterium should be considered.

Modern Identification

Because unusual environmental Gram-negative bacilli can be difficult to distinguish using conventional biochemical methods, specialized identification techniques may be helpful.

These can include:

• MALDI-TOF mass spectrometry

• Molecular identification methods

Accurate species identification may be important when determining clinical significance and antimicrobial susceptibility.

Treatment

The source lists:

Trimethoprim–sulfamethoxazole (TMP-SMX)

as treatment.

Because Methylobacterium infections are uncommon and susceptibility patterns can vary, treatment should ideally be guided by:

Antimicrobial susceptibility testing

Source Control

For infections associated with:

Central venous catheters

or

Peritoneal dialysis catheters

management may require consideration of:

Catheter removal

in addition to antimicrobial therapy, particularly when infection persists.

Treatment Principle

Clinically significant Methylobacterium infection

↓

Obtain cultures and susceptibility testing

↓

Administer an active antimicrobial

• ●

Evaluate infected catheter/device

↓

Remove or replace device when necessary

Prevention

Because these organisms are environmental and associated with water and moist surfaces, prevention in healthcare settings depends on:

• Appropriate catheter care

• Aseptic technique

• Proper handling of dialysis equipment

• Prevention of contamination of medical fluids and devices

• Appropriate infection-control practices

Methylobacterium vs. Pseudomonas

Methylobacterium

→ Aerobic Gram-negative bacillus

→ Environmental organism

→ Pink-pigmented colonies

→ Rare opportunistic infection

→ Catheter-associated bacteremia and peritonitis

Pseudomonas aeruginosa

→ Aerobic Gram-negative bacillus

→ Common opportunistic pathogen

→ Blue-green pigments may occur

→ Pneumonia, bacteremia, UTI, wound infection, and device-associated infection

The distinctive pink pigmentation is an important clue favoring Methylobacterium.

High-Yield Clinical Pattern

Immunocompromised patient

• ●

Central venous or peritoneal dialysis catheter

• ●

Bacteremia or peritonitis

• ●

Pink-pigmented aerobic Gram-negative bacillus

→ Think Methylobacterium species

Exam Essentials

Genus: Methylobacterium

Important species: M. extorquens, M. mesophilicum

Older name: Protomonas species

Type: Aerobic Gram-negative bacillus

Characteristic culture finding: Pink-pigmented colonies

Distribution: Environmental; associated with soil, plants, and water

Frequency of human infection: Very rare

Major risk group: Immunocompromised patients

Important device association: Vascular and peritoneal dialysis catheters

Major infections: Bacteremia and peritonitis

Diagnosis: Culture

Source treatment: Trimethoprim–sulfamethoxazole

ADDITIONAL TREATMENT • Ciprofloxacin • Aminoglycoside

Treatment principle: Susceptibility-guided antimicrobial therapy plus appropriate device/source control

Key clinical pearl: Methylobacterium is a rare opportunistic aerobic Gram-negative bacillus distinguished by its characteristic pink-pigmented colonies. Think of it when an immunocompromised patient with an indwelling catheter develops otherwise unexplained bacteremia or peritoneal dialysis-associated peritonitis.

Infectious Disease and Microbiology – Metagonimus yokogawai

Overview

Metagonimus yokogawai is a small intestinal trematode (fluke) that causes metagonimiasis. Human infection is usually asymptomatic, although heavier infections may produce gastrointestinal symptoms such as diarrhea, abdominal discomfort, and dyspepsia.

Humans typically acquire infection by eating raw or inadequately cooked freshwater fish containing infective metacercariae.

Classification

Genus: Metagonimus

Species: Metagonimus yokogawai

Type: Trematode helminth

Disease: Metagonimiasis

Major site of infection: Small intestine

Microbiologic Characteristics

M. yokogawai is a foodborne intestinal fluke.

The adult worms are small and inhabit the:

Small intestine

Like other trematodes, the parasite has a complex life cycle involving intermediate hosts before reaching humans.

Life Cycle

The general life cycle is:

Eggs passed in human or animal feces

↓

Development in a freshwater snail

↓

Cercariae released from the snail

↓

Cercariae penetrate freshwater fish

↓

Development into metacercariae in fish tissues

↓

Human eats raw or undercooked infected fish

↓

Metacercariae develop into adult worms in the small intestine

↓

Eggs are passed in feces

Transmission

Human infection occurs primarily through consumption of:

Raw, undercooked, or inadequately processed freshwater fish

containing:

Metacercariae

Thus, metagonimiasis is primarily a foodborne trematode infection.

Incubation Period

The incubation period is:

Not clearly established

Symptoms, when present, generally develop after the parasites mature within the intestine.

Epidemiology

Symptomatic human infection is relatively:

Rare

Cases have been reported from several regions, particularly in areas where raw or inadequately cooked freshwater fish is traditionally consumed.

Reported regions include:

• Russia

• Middle East

• India

• Indonesia

• Philippines

• China

• Japan

• Taiwan

East Asia represents an especially important endemic region for intestinal fluke infections.

Clinical Infection

The disease caused by M. yokogawai is:

Metagonimiasis

Most infections are:

Asymptomatic

Clinical severity generally increases with the number of worms present.

Gastrointestinal Manifestations

Symptomatic infection may produce:

• Diarrhea

• Abdominal discomfort

• Abdominal pain

• Dyspepsia

• Nausea

Heavy worm burdens may cause greater intestinal irritation and inflammation.

Pathogenesis

The characteristic sequence is:

Consumption of raw/undercooked infected freshwater fish

↓

Ingestion of metacercariae

↓

Development of adult flukes in small intestine

↓

Intestinal mucosal irritation

↓

Diarrhea and abdominal symptoms

Diagnosis

Diagnosis is primarily made through:

Microscopic examination of stool specimens

The characteristic finding is:

Trematode eggs in the stool

Repeated or concentrated stool examinations may improve detection when parasite burden is low.

Diagnostic Challenge

The eggs of M. yokogawai are small and can resemble those of other intestinal or hepatobiliary flukes, particularly:

Heterophyes heterophyes

Therefore, identification based solely on egg morphology may sometimes be difficult.

Treatment

The treatment described in the source is:

Praziquantel 25 mg/kg orally every 8 hours for 1 day

This provides:

3 total doses

Praziquantel is highly effective against intestinal trematode infections such as metagonimiasis.

Prevention

Prevention primarily involves:

• Thoroughly cooking freshwater fish

• Avoiding raw or inadequately cooked fish in endemic areas

• Appropriate food preparation

• Proper sanitation to reduce contamination of freshwater environments with parasite eggs

Metagonimus vs. Heterophyes

Metagonimus yokogawai

→ Small intestinal trematode

→ Raw/undercooked freshwater fish

→ Usually asymptomatic

→ Diarrhea and abdominal discomfort when symptomatic

→ Eggs detected in stool

Heterophyes heterophyes

→ Minute intestinal trematode

→ Raw, undercooked, or inadequately salted fish

→ Usually asymptomatic

→ May cause diarrhea and abdominal discomfort

→ Eggs detected in stool

The two infections can be difficult to distinguish solely by stool egg morphology.

Metagonimus vs. Clonorchis

Metagonimus yokogawai

→ Raw freshwater fish

→ Adult worms in small intestine

→ Primarily gastrointestinal symptoms

Clonorchis sinensis

→ Raw freshwater fish

→ Adult worms in biliary tract

→ Cholangitis and biliary obstruction

→ Chronic infection increases risk of cholangiocarcinoma

Thus, the exposure can be similar, but the major anatomic location differs.

High-Yield Clinical Pattern

Consumption of raw or undercooked freshwater fish

• ●

East Asian or other endemic-region exposure

• ●

Diarrhea and abdominal discomfort

• ●

Small trematode eggs in stool

→ Think Metagonimus yokogawai

→ Metagonimiasis

Exam Essentials

Organism: Metagonimus yokogawai

Type: Trematode helminth

Disease: Metagonimiasis

Major location: Small intestine

Distribution: Particularly associated with parts of Asia, with cases reported elsewhere

Transmission: Eating raw or undercooked infected freshwater fish

Infective stage for humans: Metacercariae

First intermediate host: Freshwater snail

Second intermediate host: Freshwater fish

Most infections: Asymptomatic

Major symptoms: Diarrhea, abdominal discomfort, dyspepsia

Diagnosis: Microscopic stool examination for eggs

Treatment: Praziquantel 25 mg/kg orally every 8 hours for 1 day (3 doses)

Prevention: Thoroughly cook freshwater fish

Key clinical pearl: Metagonimus yokogawai is a small intestinal fluke acquired from raw or undercooked freshwater fish. Most infections are asymptomatic, but heavier infections produce diarrhea and abdominal discomfort; diagnosis is made by detecting eggs in stool, and praziquantel is the treatment of choice.

Infectious Disease and Microbiology – Mansonella Species

Overview

Mansonella species are filarial nematodes that cause human infections collectively known as mansonellosis. Important human species include Mansonella ozzardi, M. perstans, and M. streptocerca.

Compared with several other filarial infections, Mansonella infections are generally milder and frequently asymptomatic. When symptoms occur, manifestations may include pruritus, dermatitis, hypopigmented skin lesions, edema, arthralgia, and nonspecific systemic symptoms.

Classification

Genus: Mansonella

Species:

• M. ozzardi

• M. perstans

• M. streptocerca

Type: Filarial nematode

Disease: Mansonellosis

Microbiologic Characteristics

Mansonella species are tissue-dwelling filarial nematodes.

Their life cycle involves:

Adult worms

↓

Production of microfilariae

↓

Microfilariae present in blood or skin, depending on species

↓

Uptake by an arthropod vector

↓

Development of infective larvae

↓

Transmission to another human during a subsequent bite

Incubation Period

The incubation period is:

Not clearly established

Because these infections may remain asymptomatic for prolonged periods, the interval between infection and recognizable disease can be difficult to determine.

Transmission

Mansonella species are transmitted by small biting insects.

Important vectors include:

Biting midges (Culicoides)

and, for some transmission cycles:

Blackflies (Simulium)

The specific vector differs according to the Mansonella species and geographic region.

Mansonella ozzardi

Epidemiology

M. ozzardi occurs primarily in:

• Central America

• South America

• West Indies/Caribbean

It is therefore predominantly a parasite of the:

New World

Clinical Manifestations

Many M. ozzardi infections are asymptomatic.

Symptomatic patients may develop:

• Fever

• Headache

• Pruritus

• Arthralgia

• Lymphadenopathy

• Eosinophilia

• Nonspecific skin manifestations

Microfilariae

The microfilariae of M. ozzardi circulate primarily in:

Peripheral blood

This makes examination of blood an important diagnostic approach.

Mansonella perstans

Epidemiology

M. perstans occurs predominantly in:

West and Central Africa

and has also historically been reported in parts of:

South America

Its true geographic distribution may be broader than recognized because many infections are asymptomatic or minimally symptomatic.

Clinical Manifestations

M. perstans infection is often asymptomatic but may produce:

• Pruritus

• Angioedema

• Fever

• Headache

• Arthralgia

• Abdominal discomfort

• Eosinophilia

Adult worms characteristically inhabit:

Serous body cavities and connective tissues

Microfilariae

M. perstans microfilariae circulate in:

Peripheral blood

Unlike Loa loa, their detection is not characterized by the same classic daytime periodicity.

Mansonella streptocerca

Epidemiology

M. streptocerca occurs predominantly in:

West and Central Africa

Clinical Manifestations

This species is particularly associated with:

Cutaneous disease

Possible manifestations include:

• Pruritic dermatitis

• Hypopigmented lesions

• Papular skin lesions

• Skin thickening

Because of its cutaneous manifestations, infection may resemble:

Onchocerca volvulus infection

Microfilariae

Unlike M. ozzardi and M. perstans, the microfilariae of M. streptocerca are primarily found in:

Skin

This distinction is especially important diagnostically.

Species Comparison

M. ozzardi

→ Central/South America and Caribbean

→ Microfilariae mainly in blood

M. perstans

→ Primarily Africa

→ Adult worms associated with body cavities

→ Microfilariae in blood

M. streptocerca

→ West/Central Africa

→ Cutaneous disease

→ Microfilariae primarily in skin

Clinical Infection

Overall, mansonellosis is generally considered:

Milder than many other filarial infections

A substantial proportion of infected individuals remain:

Asymptomatic

Dermatologic Disease

The source particularly emphasizes:

Hypopigmented pruritic dermatitis

This is especially relevant to M. streptocerca infection.

Patients may experience:

• Itching

• Hypopigmentation

• Papular eruptions

• Chronic localized dermatitis

Diagnosis

Diagnosis depends on the infecting species and may involve:

• Examination for microfilariae

• Skin biopsy or skin snip

• Peripheral blood examination

• Histopathology

• Serology

Blood Examination

For:

M. ozzardi

and

M. perstans

microfilariae can be detected in:

Peripheral blood

Microscopic examination of appropriately prepared blood specimens may establish the diagnosis.

Skin Examination

For:

M. streptocerca

microfilariae are primarily detected in:

Skin specimens

Histopathologic examination or examination of skin tissue can therefore be useful.

Serology

The source also lists:

Serologic testing

However, serologic assays may demonstrate cross-reactivity with other filarial infections and may not always identify the exact Mansonella species.

Treatment

The source describes a historical regimen of:

Diethylcarbamazine (DEC)

with:

50 mg on day 1

↓

100 mg on days 2 and 3

↓

50 mg every 8 hours for 3 weeks

Treatment response varies substantially among Mansonella species, so therapy should be considered species-specific rather than assuming that one regimen is equally effective for all mansonellosis.

Additional Treatment

The source identifies a possible role for:

Doxycycline

Doxycycline can be useful against filarial parasites that depend on intracellular bacterial endosymbionts called:

Wolbachia

Reduction of Wolbachia can impair the survival and reproduction of susceptible filarial worms.

Its usefulness varies among Mansonella species.

Prevention

Prevention primarily involves reducing exposure to biting insect vectors.

Measures include:

• Protective clothing

• Insect repellents

• Screening or other barriers when appropriate

• Avoiding heavy exposure to biting midges and blackflies in endemic areas

Mansonella vs. Loa loa

Mansonella

→ Biting midges/blackflies

→ Usually mild or asymptomatic

→ Blood or skin microfilariae depending on species

→ M. streptocerca causes pruritic dermatitis

Loa loa

→ Chrysops deer fly

→ Calabar swellings

→ Subconjunctival “eye worm”

→ Diurnally periodic blood microfilariae

Mansonella streptocerca vs. Onchocerca volvulus

M. streptocerca

→ Microfilariae in skin

→ Pruritic/hypopigmented dermatitis

→ Usually relatively mild

Onchocerca volvulus

→ Microfilariae in skin and ocular tissues

→ Severe pruritic dermatitis

→ Subcutaneous nodules

→ Ocular disease

→ River blindness

High-Yield Clinical Pattern

Patient from a filariasis-endemic region

• ●

Mild or asymptomatic infection

• ●

Pruritic or hypopigmented dermatitis

• ●

Microfilariae in blood or skin depending on species

→ Think Mansonella species

Exam Essentials

Genus: Mansonella

Type: Filarial nematode

Disease: Mansonellosis

Major species: M. ozzardi, M. perstans, M. streptocerca

M. ozzardi geography: Central/South America and Caribbean

M. perstans geography: Primarily Africa, with historical South American distribution

M. streptocerca geography: West and Central Africa

Vectors: Biting midges and, in some transmission cycles, blackflies

Typical severity: Usually mild or asymptomatic

Skin manifestations: Pruritus and hypopigmented dermatitis

M. ozzardi microfilariae: Blood

M. perstans microfilariae: Blood

M. streptocerca microfilariae: Skin

Diagnosis: Blood examination or skin examination depending on species, histopathology, supportive serology

Source treatment: Diethylcarbamazine

Additional treatment: Possible role for doxycycline

Prevention: Avoid bites from transmitting insects

Key clinical pearl: The most useful distinction among Mansonella species is where the microfilariae are found: M. ozzardi and M. perstans are primarily detected in blood, whereas M. streptocerca is primarily detected in the skin and can produce a pruritic, hypopigmented dermatitis resembling mild onchocerciasis.

Infectious Disease and Microbiology – Malassezia Species

Overview

Malassezia species are lipophilic yeasts that normally colonize human skin but can cause superficial and, less commonly, invasive infections. Important species include Malassezia furfur, M. pachydermatis, and M. sympodialis.

The most familiar clinical manifestation is pityriasis versicolor, formerly called tinea versicolor. Invasive infection is particularly associated with neonates, immunocompromised patients, central venous catheters, and lipid-containing total parenteral nutrition (TPN).

Classification

Genus: Malassezia

Important species:

• M. furfur

• M. pachydermatis

• M. sympodialis

Type: Lipophilic yeast

Microbiologic Characteristics

Malassezia species are:

• Yeasts

• Lipophilic

• Normal components of the cutaneous microbiota

• Particularly associated with lipid-rich areas of the skin

Because most Malassezia species require or strongly prefer external lipids for growth, laboratory culture may require:

Lipid supplementation of the culture medium

This requirement is an important microbiologic clue.

Historical Terminology

M. furfur was previously associated with the names:

Pityrosporum orbiculare

and

Pityrosporum ovale

These older names may still appear in historical literature.

Incubation Period

The incubation period is:

Unknown

Superficial disease often reflects overgrowth of an organism already present on the skin rather than acquisition followed by a clearly defined incubation period.

Epidemiology

Malassezia species have a:

Worldwide distribution

They commonly colonize human skin without producing disease.

Risk Factors for Invasive Infection

Important risk factors include:

• Total parenteral nutrition (TPN)

• Intravenous lipid emulsions

• Central venous catheters

• Prematurity

• Low birth weight

• Immunocompromised state

• Cushing syndrome

The association between Malassezia and lipid-containing intravenous therapy is particularly important.

Pityriasis Versicolor

The most common superficial infection associated with Malassezia, especially M. furfur, is:

Pityriasis versicolor

This condition was historically called:

Tinea versicolor

Despite the older name, it is caused by a yeast rather than a dermatophyte.

Clinical Manifestations

Pityriasis versicolor typically produces:

• Hypopigmented or hyperpigmented macules

• Fine scaling

• Multiple coalescing lesions

• Minimal inflammation

• Occasional mild pruritus

Commonly affected areas include:

• Upper trunk

• Chest

• Back

• Shoulders

• Neck

Pathogenesis

The organism normally exists as part of the skin microbiota.

Under favorable conditions:

Normal cutaneous colonization

↓

Increased Malassezia proliferation

↓

Transition toward pathogenic growth

↓

Superficial infection of the stratum corneum

↓

Pityriasis versicolor

Warm, humid, and lipid-rich environments can favor proliferation.

Classic Microscopic Appearance

Direct examination of skin scrapings classically demonstrates:

Short curved hyphae + clusters of yeast cells

This produces the famous appearance:

“Spaghetti and meatballs”

This is one of the most important examination associations with Malassezia.

Diagnosis of Pityriasis Versicolor

Diagnosis is often clinical and can be supported by:

• Skin scraping

• KOH preparation

• Microscopic demonstration of yeast and short hyphal elements

Culture is usually unnecessary for straightforward pityriasis versicolor.

Systemic Malassezia Infection

Although much less common, Malassezia can produce:

Fungemia and other invasive infections

These infections occur particularly in:

• Premature neonates

• Low-birth-weight infants

• Immunocompromised patients

• Patients receiving lipid-containing TPN

• Patients with central venous catheters

TPN-Associated Fungemia

A classic invasive-disease pattern is:

Central venous catheter

• ●

Lipid-rich TPN

• ●

Persistent fungemia

→ Consider Malassezia

The organism’s lipophilic nature explains its strong association with intravenous lipid emulsions.

Malassezia furfur

M. furfur can cause:

• Pityriasis versicolor

• Catheter-associated fungemia

• Systemic infection

• Peritonitis

• Rare pneumonia

Invasive disease is particularly associated with immunocompromised patients and neonates receiving intravenous lipid-containing solutions.

Peritonitis

Patients undergoing:

Continuous ambulatory peritoneal dialysis

may rarely develop Malassezia-associated:

Peritonitis

The peritoneal dialysis catheter can act as a foreign-body surface supporting persistent infection.

Malassezia pachydermatis

M. pachydermatis is particularly associated with animals, especially dogs, but can occasionally cause human infection.

The source describes systemic infection in:

Low-birth-weight infants receiving lipid emulsions through central venous catheters

Thus, neonatal intensive-care settings are an important context for recognizing this organism.

Malassezia sympodialis

M. sympodialis commonly colonizes human skin.

The source describes its role as a cause of human disease as uncertain, although Malassezia taxonomy and understanding of individual species’ clinical significance have continued to evolve.

Diagnosis of Invasive Infection

Blood Culture

Blood culture may identify the organism, but Malassezia can be difficult to recover using routine culture conditions.

Because of its lipid dependence:

Lipid-enriched culture conditions may be required

Therefore, when Malassezia fungemia is suspected, communication with the microbiology laboratory can be important.

High-Yield Diagnostic Clue

Premature neonate

• ●

Central venous catheter

• ●

Lipid-containing TPN

• ●

Unexplained fungemia

→ Think Malassezia

Treatment of Pityriasis Versicolor

Superficial pityriasis versicolor can be treated with:

Topical antifungal therapy

or, when appropriate:

Systemic azole therapy

Azole Therapy

The source describes:

Itraconazole 200 mg orally once daily for 7 days

as an effective systemic regimen.

It also describes a historical shorter regimen of:

Itraconazole 400 mg as a single dose

for some patients.

Systemic therapy is generally reserved for extensive, recurrent, or difficult-to-treat disease rather than routine limited infection.

Topical Treatment

Topical therapies are generally preferred for uncomplicated localized disease.

The source specifically lists:

Selenium sulfide 2.5%

applied once daily for approximately 30 minutes for:

2 weeks

as an effective treatment.

Topical azole antifungals are also commonly used.

Recurrence

Pityriasis versicolor can:

Recur frequently

because Malassezia remains part of the normal skin microbiota even after successful treatment.

Residual abnormalities in skin pigmentation may persist for some time after the fungal infection has been eradicated.

Treatment of Systemic Infection

Invasive Malassezia infection requires systemic antifungal therapy.

The source describes:

Intravenous azole treatment

together with:

Removal of the central venous catheter

Source Control

An especially important management principle is:

Remove the infected catheter

and, when clinically possible:

Stop or reduce lipid-containing infusions

because the catheter and lipid-rich environment can promote continued fungal growth.

Treatment Principle

Systemic Malassezia infection

↓

Systemic antifungal therapy

• ●

Central catheter removal

• ●

Address lipid-containing infusion when possible

→ Improved source control

Malassezia vs. Dermatophytes

Malassezia

→ Lipophilic yeast

→ Normal skin flora

→ Pityriasis versicolor

→ “Spaghetti and meatballs” appearance

→ Can cause TPN-associated fungemia

Dermatophytes

→ Filamentous fungi

→ Trichophyton, Microsporum, Epidermophyton

→ Cause true tinea infections

→ Infect keratinized skin, hair, and/or nails

Therefore, the historical term “tinea versicolor” can be misleading because pityriasis versicolor is not a dermatophyte infection.

High-Yield Clinical Pattern

Hypopigmented or hyperpigmented finely scaling patches on the trunk

• ●

KOH showing short hyphae and clusters of yeast

• ●

“Spaghetti and meatballs”

→ Think Malassezia furfur

→ Pityriasis versicolor

Alternative High-Yield Pattern

Premature or immunocompromised patient

• ●

Central venous catheter

• ●

Lipid-containing TPN

• ●

Fungemia

→ Think Malassezia species

Exam Essentials

Genus: Malassezia

Important species: M. furfur, M. pachydermatis, M. sympodialis

Type: Lipophilic yeast

Distribution: Worldwide

Normal habitat: Human skin

Culture requirement: Lipid supplementation may facilitate growth

Classic superficial disease: Pityriasis versicolor

Older name: Tinea versicolor

Classic microscopy: “Spaghetti and meatballs”

Systemic risk factors: Prematurity, immunosuppression, central venous catheter and lipid-containing TPN

Systemic disease: Fungemia and other catheter-associated infections

Other infections: Peritoneal dialysis-associated peritonitis and rare pneumonia

Diagnosis of superficial disease: KOH examination

Diagnosis of fungemia: Blood culture using appropriate lipid-containing conditions

Superficial treatment: Topical azoles or selenium sulfide; systemic azoles for selected cases

Invasive treatment: Systemic antifungal therapy plus catheter removal/source control

Key clinical pearl: Malassezia has two classic examination patterns: “spaghetti and meatballs” on KOH in a patient with pityriasis versicolor, and catheter-associated fungemia in a premature or immunocompromised patient receiving lipid-rich TPN.